EWM
GH icon

Empirical Wealth Management’s Guardant Health GH Stock Holding History

Empirical Wealth Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,027
Closed -$227K – 385
2020
Q3 		$227K Buy
+2,027
New +$185K 0.02% 314

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Empirical Wealth Management's GH Position: Q4 2020 in Review

Empirical Wealth Management sold out of Guardant Health (GH) in Q4 2020, closing a stake of 2,027 shares — an estimated $227K sold.

Empirical Wealth Management first reported a position in GH in Q3 2020 and held it in 1 quarter. The position peaked at $227K in Q3 2020. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

  • Empirical Wealth Management reported no remaining Guardant Health position as of Q4 2020 after selling out during the quarter.
  • Empirical Wealth Management sold 2,027 Guardant Health shares in Q4 2020, an estimated $227K.
  • Empirical Wealth Management first reported a position in Guardant Health in Q3 2020 and held it in 1 quarter.
  • Empirical Wealth Management's Guardant Health position peaked at $227K in Q3 2020.
  • 419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on Empirical Wealth Management's 13F filing for Q4 2020, filed 12 Feb 2021.